Evidence map›Paper›PMID 12586674›Full record

ReviewBMJ (Clinical research ed.)2003

Leishmaniasis: new approaches to disease control.

Clive R Davies, Paul Kaye, Simon L Croft, Shyam Sundar

Abstract readReview
In one paragraph

Review in BMJ (Clinical research ed.), 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Housing Characteristics and Leishmaniasis: A Systematic Review.The American journal of tropical medicine and hygiene · 2018
    Pooled it
  2. Interventions for Old World cutaneous leishmaniasis.The Cochrane database of systematic reviews · 2017
    Pooled it
  3. Interventions for Old World cutaneous leishmaniasis.The Cochrane database of systematic reviews · 2017
    Pooled it
  4. Vector and reservoir control for preventing leishmaniasis.The Cochrane database of systematic reviews · 2015
    Pooled it
  5. Safety and immunogenicity of ChAd63-KH vaccine in post-kala-azar dermal leishmaniasis patients in Sudan.Molecular therapy : the journal of the American Society of Gene Therapy · 2021
    Trial
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Prophylactic effect of cutaneous leishmaniasis against COVID-19: a case-control field assessment.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2022
    Article
  15. Article
  16. Article
  17. In Vitro Growth Inhibition Assays of Leishmania spp.Methods in molecular biology (Clifton, N.J.) · 2020
    Article
  18. Review
  19. Antileishmanial Evaluation of the Leaf Latex ofEvidence-based complementary and alternative medicine : eCAM · 2019
    Article
  20. Review

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Clive R DaviesDepartment of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London WC1E 7HT. clive.davies@lshtm.ac.uk
Paul Kaye
Simon L Croft
Shyam Sundar

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsAntiprotozoal AgentsCommunicable Disease ControlDisease ReservoirsDisease VectorsDog DiseasesDogsGlobal HealthHumansInsect ControlInsecticidesLeishmaniasisZoonosesAntiprotozoal AgentsInsecticides

Identifiers

PMID12586674
PMCPMC1125241

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.